Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009–2011
Jan Verhaegen(KU Leuven), Willy Peetermans(KU Leuven), Pierre Van Damme(Infectious Diseases Institute), Johan Flamaing(KU Leuven), Yves Van Laethem(Centre Hospitalier Universitaire de Saint-Pierre), Wilfried De Backer(University of Antwerp), B. Delaere(CHU Dinant Godinne UCL Namur), Filip Surmont(AstraZeneca (United Kingdom)), Koen Van Herck(University of Antwerp)
Cited by 37
Related Papers
Risk factors for community-acquired pneumonia in adults in Europe: a literature review
|Thorax|2013|861
Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019
|Journal of Internal Medicine|2020|847
Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study
|Clinical Infectious Diseases|2005|593
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
|Clinical Microbiology and Infection|2007|575